Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 
Category: Family Medicine | Nursing | Rheumatology | Anesthesiology & Pain | Journal

Back to Journal Articles

Self-Management of Low Back Pain Has Small Effects

Last Updated: November 01, 2012.

 

Meta-analysis of moderate-quality evidence shows small effects on pain, disability

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Self-management of low back pain has only small effects on pain and disability, according to the results of a systematic review and meta-analysis published in the November issue of Arthritis Care & Research.

THURSDAY, Nov. 1 (HealthDay News) -- Self-management of low back pain (LBP) has only small effects on pain and disability, according to the results of a systematic review and meta-analysis published in the November issue of Arthritis Care & Research.

Vinicius C. Oliveira, of the University of Sydney in Australia, and colleagues conducted a systematic review of the literature and meta-analysis of 13 identified randomized controlled trials in an effort to determine the effectiveness of self-management for nonspecific LBP.

The researchers found that, based on moderate-quality evidence, self-management was effective for improving pain and disability in patients with LBP. However, the effects were small, with short-term (less than six months after randomization) improvements of 3.2 and 2.3 points for pain and disability, respectively, on a 100-point scale. Over the long term (at least 12 months after randomization), pain improved by 4.8 points and disability improved by 2.1 points.

"There is moderate-quality evidence that self-management has small effects on pain and disability in people with LBP," the authors write. "Although effective when compared to minimal intervention, we are unsure if self-management provides worthwhile effects in the management of LBP. This result challenges the endorsement of self-management in treatment guidelines."

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Alemtuzumab Reduces Relapses in Relapsing-Remitting MS Next: Anticoagulation Therapy Appears to Be Safe After TAVI

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     
net

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.